 The European Commission released $ 130 million over 2014 , 2015 and 2017 under the EU Framework Program for Research and Innovation , Horizon 2020 , to support innovative small and medium-sized enterprises in the diagnostic area. The call topic focused on ` Clinical research for the validation of biomarkers and/or diagnostic medical devices '. It attracted 1194 applicants from all over Europe. The quality of the proposals was high and a large proportion of them were eligible for funding. In the majority , proposals were about in vitro diagnostics and tackled both clinical validation of new biomarkers and device optimization. The proposals dealt with various advanced technologies. One third of the proposers gave priority to the new and promising field of personalized medicine.